NCT04984239

Brief Summary

The proposed study is a Stage I successive cohort trial intended to adapt Acceptance and Commitment Therapy (ACT) to meet the specific needs of stroke survivors with aphasia ("ACT for Aphasia"). It will do so by incorporating communication supports and compensatory speech-language treatment. The goal of developing this integrated treatment is to improve successful communication participation, psychosocial adjustment, and quality of life for stroke survivors with aphasia. In the first phase of the project, the investigators will create a treatment manual with input from a stakeholder advisory board consisting of caregivers and stroke survivors with aphasia. The investigators will then recruit an initial cohort of five stroke survivors with aphasia to undergo the initial version of the treatment based and provide feedback. This will aid revision of the manual, which the investigators will then evaluate using a second cohort of 16 stroke survivors with aphasia. The investigators predict that ACT for Aphasia will be acceptable and feasible based on measures of participant satisfaction and treatment adherence. The investigators will also measure pre- to post-treatment changes in psychological distress, functional disability, quality of life, and communication participation and functioning to establish preliminary effect size estimates for this intervention, in preparation for a subsequent Stage II efficacy trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 30, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

November 2, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 22, 2024

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

April 25, 2025

Completed
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

2.2 years

First QC Date

July 20, 2021

Results QC Date

January 20, 2025

Last Update Submit

April 7, 2025

Conditions

Keywords

CounselingTherapeutics

Outcome Measures

Primary Outcomes (1)

  • Mean Scores on the Client Satisfaction Questionnaire - 8

    The Client Satisfaction Questionnaire - 8 (CSQ-8) is a brief questionnaire demonstrated to provide "efficient, sensitive, and reasonably comprehensive" measures of patient satisfaction. It has 8 questions rated on a 4-point scale (summed scores range from 8 to 32). High scores indicate high satisfaction and low scores indicate low satisfaction. The CSQ-8 is the primary measure which will determine acceptability of the proposed pilot intervention.

    Post-treatment (within one week of completing the treatment phase)

Secondary Outcomes (7)

  • Mean Scores on the Acceptance and Action Questionnaire II

    Baseline and Post-Treatment (within one week of completing the treatment phase)

  • Mean Scores on the Acceptance and Action Questionnaire - Acquired Brain Injury

    Baseline and Post-Treatment (within one week of completing the treatment phase)

  • Mean Scores on the Kessler K6 Non-specific Distress Scale

    Baseline and Post-Treatment (within one week of completing the treatment phase)

  • Mean Scores on the Stroke and Aphasia Quality of Life Scale

    Baseline and Post-Treatment (within one week of completing the treatment phase)

  • Mean Scores on the Aphasia Outcome Measure

    Baseline and Post-Treatment (within one week of completing the treatment phase)

  • +2 more secondary outcomes

Study Arms (1)

Acceptance and Commitment Therapy adapted for aphasia

OTHER

There is only a single study arm, in which the adapted intervention will be developed using a successive cohort design.

Behavioral: Acceptance and Commitment Therapy for aphasia

Interventions

The intervention will consist of Acceptance and Commitment Therapy modified to meet the needs of stroke survivors with aphasia, combined with communication strategy training.

Acceptance and Commitment Therapy adapted for aphasia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be age 18 or older.
  • Participants will have an existing diagnosis of aphasia subsequent to left hemisphere stroke.

You may not qualify if:

  • Participants with a history of other acquired or progressive neurological disease.
  • Participants whose mean modality t-score falls below 40 on the spoken language comprehension subdomain of the Comprehensive Aphasia Test.
  • Participants with semantic memory impairments as determined by the cutoff of the semantic memory component of the Comprehensive Aphasia Test.
  • Participants with unmanaged drug /alcohol dependence.
  • Participants with severe diagnose.d mood or behavioral disorders that require specialized mental health interventions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Language Rehab and Cognition Lab, Department of Communication Sciences and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh

Pittsburgh, Pennsylvania, 15260, United States

Location

MeSH Terms

Conditions

StrokeAphasia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSpeech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
William Evans
Organization
University of Pittsburgh

Study Officials

  • William Evans, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 20, 2021

First Posted

July 30, 2021

Study Start

November 2, 2021

Primary Completion

January 22, 2024

Study Completion

January 22, 2024

Last Updated

April 25, 2025

Results First Posted

April 25, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified data from this research will be shared with the wider scientific community in a timely fashion, concurrent with publication with no planned end date. Materials shared in this fashion will consist of all de-identified participant assessment and outcome data, acceptability and feasibility measures, the study protocol, statistical analysis plan, and treatment manual. These materials will be shared via the National Institute of Child Health and Human Development Data and Specimen Hub (NICHD DASH) and made additionally available by sharing the developed treatment manual and other supporting information on Dr. Evans' lab website.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data will be shared at the time of study publication without planned end to access.
Access Criteria
Anyone who wishes to access the data.
More information

Locations